Dr. Chengguo (Chris) Xing, Associate Professor, received a five-year $1,531,400 RO1 grant for his research into "Mechanisms of Anticancer Agents Selective against Drug Resistant Leukemia." Professor Rory Remmel is one of several other investigators on the project.
